NETANYA, Israel, August 4, 2011 /PRNewswire/ --
Cellcom Israel Ltd. (NYSE: CEL) (TASE: CEL) (hereinafter: the "Company"), announced today the dismissal of several purported class actions filed against the Company in December 2010, by plaintiffs alleging to be the Company's subscribers, claiming compensation for damages in connection with the network malfunction that occurred on December 1, 2010.In December 2010 nine purported class actions were filed against the company in relation to such network malfunction. Three purported class actions (for the claimed amounts of approximately NIS 200 million, 57 million and NIS 22 million) were dismissed following their respective plaintiff's request. In May 2011, the court approved a procedural agreement among the plaintiffs of the other six lawsuits, according to which all but one of these six purported class actions will be withdrawn at their respective plaintiffs' request, and that the purported class action for the claimed amount of approximately NIS 61 million will remain pending and, to the extent requested by the other plaintiffs until June 2011, be amended to include causes of actions and remedies alleged in any of the other five purported class actions. One purported class action (for the claimed amount of approximately NIS 1.18 billion) was dismissed as part of a procedural agreement. Three purported class actions (for the claimed amounts of approximately NIS 1.32 billion, NIS 1.3 billion and NIS 990 million) were dismissed after having failed to comply with the Courts' orders regarding the procedural agreement. The plaintiffs in the eighth lawsuit (for the claimed amount of NIS 25 million) also requested to withdraw, as part of the procedural agreement. To date, no amendment to the remaining purported class action (according to the procedural agreement) was requested.
For additional details see the Company's annual report on Form 20-F for the year ended December 31, 2010, under "Item 8 - Financial Information - A. Consolidated Statements and Other Financial Information -Legal Proceedings".
NETANYA, Israel, November 2, 2011 /PRNewswire/ --
Cellcom Israel Ltd. (NYSE: CEL) (the "Company") announced that a purported class action lawsuit against the Company was filed in the District Court of Jerusalem, by plaintiffs alleging to be subscribers of the Company, in connection with the allegation that the Company raised tariffs for business customers, unlawfully and in violation of its agreements with them.
The total amount claimed from the Company, if the lawsuit is certified as a class action, is estimated by the plaintiffs to be at least hundreds of millions of NIS.
At this preliminary stage, the Company is unable to assess the lawsuit's chances of success.
NETANYA, Israel, August 23, 2011 /PRNewswire/ --
Cellcom Israel Ltd. (NYSE: CEL) (the "Company") announced that a purported class action lawsuit against the Company and two other cellular operators was filed in the District Court of Central Region, by plaintiffs alleging to be subscribers of the defendants. The plaintiffs allege that the defendants unlawfully and in violation of their licenses charged their subscribers based on units which are different than the units allegedly required by the defendants' licenses, for calls initiated or received by the subscribers while abroad.
The plaintiffs did not state any estimate of the total amount claimed from any of the defendants, if the lawsuit is certified as a class action.
At this preliminary stage, the Company is unable to assess the lawsuit's chances of success.
Recent CEL News
- Celadon Pharmaceuticals PLC Investor Site Visit – Tuesday 22 October 2024 • RNS Non-Regulatory • 10/04/2024 12:00:01 PM
- Celadon Pharmaceuticals signs sales contract with Valeos Pharma • Alliance News • 10/02/2024 05:32:42 PM
- Celadon Pharmaceuticals PLC New Sales Contract with a Healthcare Company • RNS Regulatory News • 10/02/2024 06:00:02 AM
- Bank of Ireland promotes ex-Barclays exec to chair • Alliance News • 09/30/2024 01:07:40 PM
- Celadon Pharmaceuticals PLC Departure of Chief Financial Officer • RNS Regulatory News • 09/30/2024 06:05:00 AM
- Celadon Pharmaceuticals PLC Interim Results • RNS Regulatory News • 09/30/2024 06:00:10 AM
- Celadon Pharmaceuticals PLC Admission of Shares and Total Voting Rights • RNS Regulatory News • 09/17/2024 08:28:59 AM
- Celadon Pharmaceuticals shares dive as laments delayed funding • Alliance News • 09/11/2024 12:54:16 PM
- Celadon Pharmaceuticals PLC Equity Fundraise and Update on Financial Position • RNS Regulatory News • 09/11/2024 06:05:00 AM
- Celadon Pharmaceuticals PLC Strategic collaboration with Valeos • RNS Regulatory News • 09/11/2024 06:00:08 AM
- Celadon Pharmaceuticals confirms future payments amid funding delays • Alliance News • 08/23/2024 10:51:28 AM
- Celadon Pharmaceuticals PLC Update on Financial Position • RNS Regulatory News • 08/23/2024 06:00:06 AM
- Celadon Pharmaceutical shares dive amid delayed receipt of funds • Alliance News • 08/12/2024 08:59:11 AM
- Celadon Pharmaceuticals PLC Update on Operations and Financial Position • RNS Regulatory News • 08/12/2024 06:00:06 AM
- Gateley earnings fall; 4Global revenue rises • Alliance News • 07/16/2024 06:25:24 PM
- Celadon Pharmaceuticals PLC Successful Completion of Eighth Harvest of 2024 • RNS Regulatory News • 07/16/2024 06:00:07 AM
- Celadon Pharmaceuticals PLC Third Admission of Shares • RNS Regulatory News • 07/15/2024 12:58:13 PM
- Celadon Pharmaceuticals PLC Result of AGM • RNS Regulatory News • 06/28/2024 06:00:12 AM
- Celadon Pharmaceuticals PLC Second Admission of Shares • RNS Regulatory News • 06/07/2024 06:00:09 AM
- No Headline Available • Alliance News • 06/03/2024 05:01:12 PM
- Celadon Pharmaceuticals PLC Publication of Annual Report & Notice of AGM • RNS Regulatory News • 06/03/2024 04:45:01 PM
- Celadon ships to US; Oxford BioDynamics-Goodbody pact • Alliance News • 05/23/2024 08:08:53 PM
- Celadon Pharmaceuticals PLC Supply of Products to New US Customer • RNS Regulatory News • 05/23/2024 06:00:13 AM
- Celadon Pharmaceuticals PLC Exercise of Share Options and Total Voting Rights • RNS Regulatory News • 05/15/2024 01:45:01 PM
- Headlam warns of loss; EnSilica predicts revenue rise • Alliance News • 05/14/2024 06:41:32 PM
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • SMX • Oct 3, 2024 7:00 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM